S&P 500
(1.17%) 5 107.23 points
Dow Jones
(0.50%) 38 275 points
Nasdaq
(2.20%) 15 955 points
Oil
(0.08%) $83.64
Gas
(-1.16%) $1.619
Gold
(0.32%) $2 350.10
Silver
(-0.60%) $27.19
Platinum
(0.14%) $921.75
USD/EUR
(0.32%) $0.935
USD/NOK
(0.66%) $11.02
USD/GBP
(0.14%) $0.800
USD/RUB
(-0.32%) $91.88

Realtime updates for Redwood Pharma AB [REDW.ST]

Exchange: STO Sector: Healthcare Industry: Biotechnology
Last Updated26 Apr 2024 @ 11:21

-7.62% SEK 1.030

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 11:21):

Redwood Pharma AB engages in the development of ophthalmic pharmaceutical therapies for unmet market needs. The company's lead development product is RP101, an eye drop that treats severe chronic dry eye disease in post-menopausal women...

Stats
Today's Volume 11 184.00
Average Volume 49 957.00
Market Cap 21.20M
EPS SEK-0.0135 ( 2023-09-30 )
Next earnings date ( SEK0 ) 2024-06-27
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E 0.0700
ATR14 SEK0.0300 (2.91%)

Redwood Pharma AB Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Redwood Pharma AB Financials

Annual 2023
Revenue: SEK0
Gross Profit: SEK-544 836 (0.00 %)
EPS: SEK-5.34
FY 2023
Revenue: SEK0
Gross Profit: SEK-544 836 (0.00 %)
EPS: SEK-5.34
FY 2022
Revenue: SEK0
Gross Profit: SEK0 (0.00 %)
EPS: SEK-28.31
FY 2021
Revenue: SEK0.00
Gross Profit: SEK0.00 (0.00 %)
EPS: SEK-0.344

Financial Reports:

No articles found.

Redwood Pharma AB

Redwood Pharma AB engages in the development of ophthalmic pharmaceutical therapies for unmet market needs. The company's lead development product is RP101, an eye drop that treats severe chronic dry eye disease in post-menopausal women. It uses IntelliGel, a supramolecular smart drug delivery system for development of topical formulation for ophthalmic uses, as well as for administration to the front of the eye. Redwood Pharma AB is based in Stockholm, Sweden.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators